tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Ownership - Who Owns Allogene Therapeutics?

Compare
1,447 Followers

Allogene Therapeutics (ALLO) Ownership Overview

10.40%21.78%47.46%7.88%12.47%
10.40% Insiders
47.46% Other Institutional Investors
7.88% ETFs
12.47% Public Companies and Individual Investors
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 77.13% of the company’s stock is owned by Institutional Investors, 10.40% is owned by Insiders, and 12.47% is owned by Public Companies and Individual Investors.
The ownership structure of Allogene Therapeutics (ALLO) stock is a mix of institutional, retail, and individual investors. Approximately 69.24% of the company’s stock is owned by Institutional Investors, 10.40% is owned by Insiders, and 7.88% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 10, 2024
xxxxxxxxxxxxx
$19916
Dec 09, 2024
xxxxxxxxxxxxx
$19917

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$6366487
Mar 31, 2025
xxxxxxxxxxxxx
$7200486

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,265,330Institution5.61%16,803,502
11,009,103Insider5.03%15,082,471
8,189,765Insider3.74%11,219,978
7,827,665Institution3.58%10,723,901
6,637,353Institution3.03%9,093,174
6,180,732Institution2.83%8,467,603
4,931,840Institution2.25%6,756,621
4,360,608Institution1.99%5,974,033
3,265,529Institution1.49%4,473,775
2,964,570Institution1.36%4,061,461

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
12,265,330Institution5.61%16,803,502
6,637,353Institution3.03%9,093,174
3,265,529Institution1.49%4,473,775
2,964,570Institution1.36%4,061,461
2,936,094Institution1.34%4,022,449
2,500,000Institution1.14%3,425,000
2,204,834Institution1.01%3,020,623
1,827,970Institution0.84%2,504,319
1,741,870Institution0.80%2,386,362
1,463,721Institution0.67%2,005,298

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,278,056Institution1.96%5,005,326
3,169,071Institution1.45%4,341,627
2,358,985Institution1.08%2,760,012
1,120,665Institution0.51%1,535,311
815,553Institution0.37%1,117,308
712,968Institution0.33%976,766
638,898Institution0.29%747,511
459,502Institution0.21%537,617
410,272Institution0.19%562,073
399,725Institution0.18%547,623

FAQ

Who Owns Allogene Therapeutics Inc (ALLO)?
According to the latest TipRanks data, approximately 47.46% of the company's stock is held by institutional investors, 10.40% is held by insiders, and 12.47% is held by retail investors.
    What percentage of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 47.46% of Allogene Therapeutics Inc (ALLO) stock is held by institutional investors.
      What percentage of Allogene Therapeutics Inc (ALLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 12.47% of Allogene Therapeutics Inc (ALLO) stock is held by retail investors.
        Who owns the most shares of Allogene Therapeutics Inc (ALLO)?
        SMALLCAP World Fund Inc owns the most shares of Allogene Therapeutics Inc (ALLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis